<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774718/" ref="ordinalpos=4858&amp;ncbi_uid=2465100&amp;link_uid=PMC2774718" image-link="/pmc/articles/PMC2774718/figure/f8/" class="imagepopup">FIG. 8. From: Molecular Mechanisms and Clinical Implications of Reversible Protein S-Glutathionylation. </a></div><br /><div class="p4l_captionBody"><b>S-glutathionylation as a regulator of the JNK and MAPK signaling pathways in cancer.</b> This figure depicts several sites in the JNK pathway and in other signaling pathways in cancer cells where reversible S-glutathionylation may serve as a potential regulatory mechanism (e.g., Ras-SSG, MAPK/ERK kinase kinase 1 (MEKK1)-SSG, c-Jun-SSG, glutathione S-transferase (GSTpi-SSG).</div></div>